IMAX Corporation (IMAX) PT Raised to $32 at Benchmark

Benchmark analyst Mike Hickey raised the price target on IMAX Corporation (NYSE: IMAX) to $32.00 (from $30.00) while maintaining a Buy rating.

The analyst commented, "IMAX delivered a strong Q2 2025, outperforming consensus expectations with $91.7M in revenue and $36.7M in adjusted EBITDA after non-controlling interest, up 10% vs. consensus. The company posted a record Q2 North American box office of $143M and grew global box office 41% YoY to $281.1M, driving global market share to 3.6% on less than 1% of screens. AEBITDA margin rose 780bps to 42.6%. Installations increased 50% YoY to 36, and total signings YTD reached 123, approaching full-year 2024 levels. Management reaffirmed its $1.2B full-year GBO guidance and cited strong Q3 momentum."

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• Air T reports revenue jump but widens operating loss in Q1 fiscal 2027
• Jane Street Took $15 Billion Hit In July Tied To Situational Awareness - Reuters